Predictors of HBeAg seroconversion after long-term nucleos(t)ide analogues treatment for chronic hepatitis B: a multicenter study in real clinical setting

AIMS: To evaluate the HBeAg seroconversion rate in real clinical setting and explore its predictors in long-term nucleos(t)ide analogues (NAs) treatment for chronic hepatitis B (CHB). METHODS: 251 patients were recruited from January 2001 to September 2009 in four hospitals in Hebei province, China,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Weiyan, Wang, Yadong, Shen, Chuan, Ji, Ru, Zhang, Li, Zhao, Xin, Su, Miao, Zhang, Ying, He, Wenyan, Cao, Jianguo, Hao, Yanshuang, Chen, Shengpeng, Zhao, Caiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427966/
https://www.ncbi.nlm.nih.gov/pubmed/28351603
http://dx.doi.org/10.1016/j.bjid.2017.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427966/
https://www.ncbi.nlm.nih.gov/pubmed/28351603
http://dx.doi.org/10.1016/j.bjid.2017.03.001

Ejemplares similares